Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC

12 Sept 2023

Abstract excerpt

Abstract Background The development of drug resistance and high mortality rates are the major problems observed in non-small cell lung cancer (NSCLC). Biomarkers indicating and predicting disease development towards these unfavorable directions are therefore on high demand. Many studies have demonstrated that changes in miRNAs expression may be associated with a response to treatment and disease prognosis, thus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circular RNAs in diseases
Share to Lung Cancer Treatments and Mutations
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37697308
DOI: 10.1186/s12885-023-11365-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLCPMID 37697308Read ↗

Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.Semantic proximity Read ↗

miR-181 Expression is Associated With The Prognosis in Lung Cancer.Semantic proximity Read ↗

Plasma miR ‐1247‐5p, miR ‐301b‐3p and miR ‐105‐5p as potential biomarkers for early diagnosis of non‐small cell lung cancerSemantic proximity Read ↗

Circ_0092012 knockdown restrains non-small cell lung cancer progression by inhibiting cell malignant phenotype and immune escape through microRNA-635/programmed death ligand 1 axis.Semantic proximity Read ↗

Association between methyltransferase-like 3 and non-small cell lung cancer: pathogenesis, therapeutic resistance, and clinical applicationsSemantic proximity Read ↗

A plasma miRNA-based classifier for small cell lung cancer diagnosisSemantic proximity Read ↗

Integrative Bioinformatics Analysis Identifies Noninvasive miRNA Biomarkers for Lung CancerSemantic proximity Read ↗

MiR-320a is associated with cisplatin resistance in lung adenocarcinoma and its clinical value in non-small cell lung cancer: A comprehensive analysis based on microarray dataSemantic proximity Read ↗

Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitroSemantic proximity Read ↗

Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR dataSemantic proximity Read ↗

Circulating microRNA-339-5p and -21 in plasma as an early detection predictors of lung adenocarcinoma.Semantic proximity Read ↗

Identification of exosomal microRNA panel as diagnostic and prognostic biomarker for small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.